Glaucoma is
a disease of eye which is caused by excessive increase of fluid pressure within
the eye. Glaucoma is caused due to mechanical compression or decreased blood
flow in the optic nerve of the patient’s eye. If not treated properly, it may
lead to mild loss of vision and even blindness. Treatment of glaucoma includes
laser therapies, pharmaceutical drugs and surgical procedures.
Ocular
hypertension is one of the major causes due to which glaucoma occurs in
patients. Glaucoma mostly occurs at the age over 40, but it may also occur in
children, young adults, and infants. Diagnosis of glaucoma can be done through
a simple eye examination with the help of tonometry, an instrument used for
measuring intraocular pressure, by an ophthalmologists and optometrist.
Prevention of glaucoma is difficult; however, if diagnosed and treated at an
early stage, the disease can be controlled by using eye drops prescribed by
doctor, microsurgery or by laser surgery. Glaucoma can damage the vision of the
affected eye permanently; in first stage it decreases the peripheral vision and
if not treated, it can lead to blindness.
Request to Get the
Sample Pages at:
Some of the
major factors driving the growth of glaucoma therapeutics market are aging
population of developed countries, development of advanced glaucoma drug
delivery devices and rising global healthcare expenditures. Stringent
government regulation and marketing approval, side effects of glaucoma
medications and long development process of the glaucoma products are some of
the major factors restraining the growth of global glaucoma therapeutics
market.
Make Enquiry Before
Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=glaucoma-therapeutics-market
North
America was the largest glaucoma therapeutics market in 2014, attributed to
high per capita expenditure on healthcare in this region. It is followed by
Europe and Asia-Pacific. Asia-Pacific region is also the fastest growing
glaucoma therapeutics market, owing to the aging population of Japan coupled
with the increasing healthcare expenditure of developing countries, such as
India and China. Asia-Pacific glaucoma therapeutics market is further expected
to witness growth and surpass North America market in terms of largest market during
the coming years.
Some of the
major competitors in global glaucoma therapeutics market are Pfizer Inc.,
Allergen Inc., Novartis A.G., Merck & Co. Inc., Aerie Pharmaceuticals Inc.,
Inotek Pharmaceuticals Corp., Carl Zeiss Meditec Inc., Acadia Pharmaceuticals
Inc., Neurotech Pharmaceuticals Inc., NicOx SA, Santen Pharmaceuticals Co.
Ltd., Otsuka Holdings Co. Ltd., SIFI SpA, and Valeant Pharmaceuticals
International Inc.
